. Jarvi is the Director of the Murray Koffler Urologic Wellness Centre and Head of Urology at the Mount Sinai Hospital. He is a Professor of Surgery at the University of Toronto and directs the Male Infertility Program at the University of Toronto.

Dr. Jarvi completed his Urology Residency at the University of Toronto and then had Fellowship training in Male Reproduction with Dr. Dale McClure at the University of California at San Francisco and a basic science fellowship in Male Reproduction supervised by Dr. Claude Gagnon at McGill University in Montreal.

Dr. Jarvi then began the Male Reproductive Medicine program at the University of Toronto. This program is a centre of excellence for the management of male infertility and has grown into the largest clinical program of its kind in Canada and one of the largest in North America. Close to 1000 new patients are seen yearly with over 5000 patient visits.

The program involves a multi-disciplinary team from Pathology and Laboratory Medicine, Department of Medical Imaging, Medical Genetics and Obstetrics and Gynecology. The centre acts as a tertiary referral centre for difficult infertility cases. At the clinic, patients are seen from all over Canada and from many parts of the world.

Dr. Jarvi has been at the forefront of the use of new and innovative surgical techniques in Canada. He was the first in Canada to perform sperm aspiration for in-vitro fertilization, use a minimally invasive technique to retrieve sperm, use the sperm mapping procedure to retrieve sperm, use the newest technique of micro-surgical reconstruction of an obstruction of the reproductive tract.

He has also developed innovative techniques of surgery which are now in widespread use. These include a minimally invasive technique to perform a vasectomy reversal and techniques to surgically bridge gaps in the reproductive tract.

Dr. Jarvi has helped train over 20 urology fellows, 45 urology residents, 20 gynecology fellows, 20 gynecology residents, 5 graduate students, 4 undergraduate students and innumerable medical students. The urology fellows have gone on to develop their own centres for the treatment of male infertility in hospitals all across Canada, the United States, South America and the Middle East.

Dr. Jarvi’s research has focused on:

Biomarkers to diagnose male infertility (work funded by PSI and Canadian Urology Association); Genetic causes of male infertility; Cystic fibrosis mutations were identified by our group in a high proportion of men with infertility (supported by NIH, Cystic Fibrosis Foundation of Canada); Novel mutations where he has found novel mutations in men with infertility (supported by CIHR) sperm DNA damage; Infection in male infertility (supported by NIH, PSI, Kidney Foundation); Identification of novel non-cultureable infections in prostatitis (supported by NIH, PSI); Identification of new biomarkers for the early detection of prostate cancer: (supported by the Canadian Urology Association).

Dr. Jarvi has published over 70 articles in peer reviewed journals, has been an invited speaker in North and South America, Europe and the Middle East and acts as an advisor to the Government of Canada on issues related to male infertility.

If you are looking for local services or  treatment  from your Local Urologist in the office or hospital from a Local Urologist, contact a provider such as ( Dr. Keith Jarvi ) to inquire if they are accepting patients or you need a referral.   Phone number to book an appointment (416) 586-4800 Ext. 8867

The speaker in the video may have no association with ( Dr. Keith Jarvi, Local Urologist Toronto, ON ). 
( Dr. Keith Jarvi, Local Urologist Toronto, ON ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist about the information you learnt from the videos in regards to treatments and procedures the Local Urologist could  perform and if they would be appropriate for you. Remember good information is the corner stone to understanding your condition or disease. Please contact ( Dr. Keith Jarvi, Local Urologist Toronto, ON ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal  conditions

 

Urology Information: 

Depending on the case, prostate cancer may be safely followed with active surveillance or watchful waiting rather than surgery, chemotherapy or radiation. Ask your local urologist for more information on Contino®, an alternative to diapers or surgery. Patients may be referred to a urologist if their physician suspects they may need treatment for a condition relating to bladder, urethra, ureters, kidneys, and adrenal glands.

Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Depending on the case, prostate cancer may be safely followed with active surveillance or watchful waiting rather than surgery, chemotherapy or radiation. Prostate cancer is the most common cancer in Canadian men. It is most common in older men

Colorectal ; Other Cancers: Dietary fibre and antioxidant intake are two of the biggest considerations
when it comes to reducing the risk of preventable cancers, such as colorectal cancer. Beets and beet
greens are among the most abundant sources of both these important nutrients.

Your body will digest and absorb short-chain carbohydrates (also called rapid-acting carbohydrates) more quickly, which can actually cause a spike in the blood sugar. Some examples would be juice, white bread and sugar. Longer-chain carbohydrates take the body longer to digest and absorb, causing less of an effect on the blood sugar. Examples are legumes, oats, barley and berries. These carbohydrates can play a very important role in diabetes management. 

Surgery for prostate cancer is called a radical prostatectomy and involves the removal of the prostate gland with or without some lymph nodes in the pelvis. This can be performed with key-hole surgery called laparoscopy (usually done with a robot to help the surgeon) or through a small incision in the lower part of the abdomen called open surgery.

Once prostate cancer is diagnosed, one of the first things doctors do is determine how aggressive cancers are (also known as tumor grade) and how much of the prostate is involved and if the cancer has spread outside of the gland to nearby tissues or other parts of the body (otherwise known as tumor stage). This information is important to help determine the treatment options for men newly diagnosed with prostate cancer. What is tumor Grade?:

When a tumor is discovered on prostate biopsy, the aggressiveness of the cancer can be classified into a category called tumor grade. In general, the higher the grade, the more aggressive cancers are. In prostate cancer, the grade is most commonly described as a Gleason Score. The Gleason Score of a prostate cancer is between 2-10. Scores 6 or less are considered mildly aggressive, 7 is considered intermediate aggressive, and scores 8-10 are considered very aggressive. In summary, the higher the Gleason Score, the more aggressive the cancer is, and the greater the risk of cancer spreading outside of the prostate gland. What is tumor Stage?: Often seeing a local urologist in Toronto can help.